Boston Private Bank & Trust’s Pacira BioSciences PCRX Stock Holding History

Boston Private Bank & Trust’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$2K	Hold	24	–	–	﹤0.01%	973
2014 Q4	$2K	Sell	24 -976	-98%	-$92.3K	﹤0.01%	1050
2014 Q3	$97K	Hold	1,000	–	–	﹤0.01%	477
2014 Q2	$92K	Hold	1,000	–	–	﹤0.01%	489
2014 Q1	$70K	Hold	1,000	–	–	﹤0.01%	536
2013 Q4	$57K	Buy	1,000 +140	+16%	+$7.36K	﹤0.01%	566
2013 Q3	$41K	Buy	860 +235	+38%	+$8.56K	﹤0.01%	588
2013 Q2	$18K	Buy	+625	New	+$18.1K	﹤0.01%	688

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Private Bank & Trust's PCRX Position: Q1 2015 in Review

Boston Private Bank & Trust held its Pacira BioSciences (PCRX) position steady in Q1 2015 at 24 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Boston Private Bank & Trust first reported a position in PCRX in Q2 2013 and has held it in 8 quarters since. The position peaked at $97K in Q3 2014. 205 funds tracked by Wall St. Rank hold PCRX as of Q1 2015.

Boston Private Bank & Trust held 24 shares of Pacira BioSciences worth $2K as of Q1 2015.
Boston Private Bank & Trust left its Pacira BioSciences share count unchanged in Q1 2015.
Pacira BioSciences made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #973 holding.
Boston Private Bank & Trust first reported a position in Pacira BioSciences in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Pacira BioSciences position peaked at $97K in Q3 2014.
205 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.